The Patient-Centered Oncology Care® (PCOC) conference, taking place in a hybrid format September 23-24, 2021, provides a space for oncologists, payers, health care system leaders, and others to delve into different possibilities to improve care, according to Joseph Alvarnas, MD, of City of Hope, editor-in-chief of Evidence-Based Oncology™ and co-chair of the meeting.
The Patient-Centered Oncology Care® (PCOC) conference, taking place in a hybrid format September 23-24, 2021, provides a space for oncologists, payers, health care system leaders, and others to delve into different possibilities to improve care, according to Joseph Alvarnas, MD, of City of Hope, editor-in-chief of Evidence-Based Oncology™ and co-chair of the meeting.
Transcript
Which stakeholders should plan to participate in PCOC?
The beauty of this meeting is that it really helps to empower stakeholders across the breadth of oncology. So we're not just talking about clinicians, we're not just talking about leaders of health care systems, but also the other essential members: those in pharma, those who are leading by helping develop pathways, those who are leading on the payer side by really exercising new levels of creativity in payment systems.
Part of the beauty of this meeting is that you have stakeholders who often have their own meetings and often have separate conversations, and what you find not only in the panels, but also in the breaks in between when people have a chance to visit and talk and chat—whether it's by a virtual means or an in-person means—you find this great cross-pollination of ideas and the general level of excitement that builds in that room as all of these diverse stakeholders, who fairly rarely engage in these kinds of conversations, go deeper and deeper into the future. The beauty of oncology is what makes it so exciting, the diversity of stakeholders, and the depth of conversations that they have around making our system much better.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More